Treatment of Cardiovascular Diseases - Estonia
Estonia- The revenue in Estonia's Treatment of Cardiovascular Diseases market is forecasted to reach US$132.40m in 2024.
- It is expected to exhibit an annual growth rate (CAGR 2024-2029) of 5.05%, leading to a market volume of US$169.30m by 2029.
- Comparatively, United States is projected to generate the highest revenue in the global market, amounting to US$136.00bn in 2024.
- Estonia's healthcare system is increasingly focusing on preventive measures and early detection in the treatment of cardiovascular diseases.
Definition:
Treatments of Cardiovascular Diseases refers to the treatment of patients with diseases or disorders that affect the circulatory system, including coronary artery disease, heart disease, and stroke. During their stay in the hospital, patients are provided with necessary surgical procedures, medication management, and any medical intervention that is needed to manage their symptoms, prevent complications, and further progression of the disease, thus improving their overall health and well-being.
Additional information:
The Treatments of Cardiovascular Diseases market comprises revenues and average revenue per capita. Market values represent revenues paid to hospitals by the respective healthcare payers (including VAT, if applicable). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.
In-Scope
- Diagnostic testing
- Medication received during inpatient treatments
- Continuous monitoring, such as tracking heart rate or blood pressure
- Interventional procedures, such as angioplasty or stenting
Out-Of-Scope
- Long-term rehabilitative care
- Home-based rehabilitative care
